Younghoon Kim1,2, Ye-Young Rhee3, Xianyu Wen4, Nam-Yun Cho2, Jeong Mo Bae1,2, Woo Ho Kim1, Gyeong Hoon Kang5,6. 1. Department of Pathology, Seoul National University College of Medicine, Seoul, Korea. 2. Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. 3. Pathology Center, Seegene Medical Foundation, Seoul, Korea. 4. Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. 5. Department of Pathology, Seoul National University College of Medicine, Seoul, Korea. ghkang@snu.ac.kr. 6. Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. ghkang@snu.ac.kr.
Abstract
BACKGROUND: High density of tumor-infiltrating lymphocyte (TIL) is known to be associated with prolonged survival time, whereas tumoral-L1 hypomethylation has been associated with shortened survival time in patients with gastric cancer (GC). Since L1-methylation level is high in lymphocytes, higher density of TIL could lead to higher measurement of L1-methylation level in cancer tissues which contain cancer cells as well as non-neoplastic cells, including TIL. Putative interaction of TIL in the relationship between L1-methylation level and survival led us to explore combinatory statuses of tumoral-L1-methylation level and TIL density as a prognostic marker in GC. METHODS: TIL and tumoral-L1-methylation level were measured in advanced GC samples (n = 491), using CD3 immunohistochemistry and pyrosequencing-methylation analysis, respectively. TIL density was measured in tumor center and invasive front areas. RESULTS: TIL density correlated with tumoral-L1-methylation level but the relationship was weak. Combinatory statuses of L1-methylation level and CD3 TIL density were found to be statistically significant in survival analysis. Multivariate analysis revealed that the relationship between combinatory statuses and survival was independent. Prognostic value of the combinatory statuses at invasive front was significant in an independent set. CONCLUSIONS: Our findings indicate that tumoral-L1-methylation level is correlated with TIL density and that combinatory statuses might help to find a subset of GCs with worse clinical outcome in GCs with low-L1-methylation status or a subset of GCs with better clinical outcome in GCs with high-L1-methylation status.
BACKGROUND: High density of tumor-infiltrating lymphocyte (TIL) is known to be associated with prolonged survival time, whereas tumoral-L1 hypomethylation has been associated with shortened survival time in patients with gastric cancer (GC). Since L1-methylation level is high in lymphocytes, higher density of TIL could lead to higher measurement of L1-methylation level in cancer tissues which contain cancer cells as well as non-neoplastic cells, including TIL. Putative interaction of TIL in the relationship between L1-methylation level and survival led us to explore combinatory statuses of tumoral-L1-methylation level and TIL density as a prognostic marker in GC. METHODS: TIL and tumoral-L1-methylation level were measured in advanced GC samples (n = 491), using CD3 immunohistochemistry and pyrosequencing-methylation analysis, respectively. TIL density was measured in tumor center and invasive front areas. RESULTS: TIL density correlated with tumoral-L1-methylation level but the relationship was weak. Combinatory statuses of L1-methylation level and CD3 TIL density were found to be statistically significant in survival analysis. Multivariate analysis revealed that the relationship between combinatory statuses and survival was independent. Prognostic value of the combinatory statuses at invasive front was significant in an independent set. CONCLUSIONS: Our findings indicate that tumoral-L1-methylation level is correlated with TIL density and that combinatory statuses might help to find a subset of GCs with worse clinical outcome in GCs with low-L1-methylation status or a subset of GCs with better clinical outcome in GCs with high-L1-methylation status.
Entities:
Keywords:
Gastric cancer; L1 element; Prognosis; T lymphocyte
Authors: Young Seok Song; Younghoon Kim; Nam Yun Cho; Han Kwang Yang; Woo Ho Kim; Gyeong Hoon Kang Journal: Gastric Cancer Date: 2015-01-22 Impact factor: 7.370
Authors: Carmen S Tellez; Lanlan Shen; Marcos R H Estécio; Jaroslav Jelinek; Jeffrey E Gershenwald; Jean-Pierre J Issa Journal: Melanoma Res Date: 2009-06 Impact factor: 3.599
Authors: Kosuke Mima; Jonathan A Nowak; Zhi Rong Qian; Yin Cao; Mingyang Song; Yohei Masugi; Yan Shi; Annacarolina da Silva; Mancang Gu; Wanwan Li; Tsuyoshi Hamada; Xuehong Zhang; Kana Wu; Jeffrey A Meyerhardt; Hideo Baba; Edward L Giovannucci; Andrew T Chan; Charles S Fuchs; Shuji Ogino; Reiko Nishihara Journal: Oncotarget Date: 2016-08-23
Authors: Marcos R H Estécio; Vazganush Gharibyan; Lanlan Shen; Ashraf E K Ibrahim; Ketan Doshi; Rong He; Jaroslav Jelinek; Allen S Yang; Pearlly S Yan; Tim H-M Huang; Eloiza H Tajara; Jean-Pierre J Issa Journal: PLoS One Date: 2007-05-02 Impact factor: 3.240